Halozyme CEO Helen Torley sells $1.7 million in inventory By Investing.com
In latest buying and selling exercise, Helen Torley, the President and CEO…
Halozyme Therapeutics hits 52-week excessive, reaching $56.66 By Investing.com
Halozyme (NASDAQ:) Therapeutics, Inc. (HALO) has reached a brand new 52-week excessive,…
